Hello,
Here are the minutes of the call. The next call will be in one week,
October 25th at 2pm CET.
- We discussed some analysis updates - analysis seems to be progressing
quite fast now and many things are finished or close to finished, as
they should by now.
- Thomas presented RNA editing analyses. We have 113 cases where known
RNA editing sites show editing in our data using very stringent
criteria. 11 of these show significant population differences. Tuuli has
the data and will do QTL analysis on the proportion of editing.
- Tuuli presented allele-specific splicing analyses. ASAS appears to be
as common as ASE and we can assess that for thousands of sites per
individual. ASE and ASAS signals are commonly shared, suggesting that
transcript structure variation is major contributor to ASE signal.
- We continued with a QC subgroup call and went through Peter's outline
of figures for the QC companion. Most of the analysis is done, and Peter
will put together a todo list of the remaining action items.
best,
Tuuli
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
On /17/1012 19:41 PM, Tuuli Lappalainen wrote:
Hello,
We'll have a Geuvadis analysis group call on Thursday October 18th at
2pm CET.
On the agenda:
- analysis updates; in particular asQTLs and miRNA-mRNA interactions
- RNA editing presentation by Thomas
- if there's time, allele-specific alternative splicing slides by Tuuli
best,
Tuuli
Call details:
Germany +49 692 573 804 41 <tel:%2B49%20692%20573%20804%2041>
Netherlands +31 108 920 271 <tel:%2B31%20108%20920%20271>
Spain +34 931 816 661 <tel:%2B34%20931%20816%20661>
Sweden +46 840 309 949 <tel:%2B46%20840%20309%20949>
Switzerland +41 58 262 07 22 <tel:%2B41%2058%20262%2007%2022>
United Kingdom +44 203 370 57 19 <tel:%2B44%20203%20370%2057%2019>
United States +1 646 381 08 89 <tel:%2B1%20646%20381%2008%2089>
/Access code: 611683
/
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
_______________________________________________
Geuvadis_rna_analysis mailing list
Geuvadis_rna_analysis(a)lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_rna_analysis